Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7666) 7666
Newspaper Article (97) 97
Magazine Article (59) 59
Book Chapter (17) 17
Book / eBook (10) 10
Newsletter (5) 5
Conference Proceeding (4) 4
Web Resource (2) 2
Dissertation (1) 1
Government Document (1) 1
Publication (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5487) 5487
science & technology (4971) 4971
life sciences & biomedicine (4686) 4686
chelating agents - therapeutic use (3017) 3017
male (2621) 2621
animals (2515) 2515
female (2226) 2226
iron chelating agents - therapeutic use (1835) 1835
biological and medical sciences (1605) 1605
medical sciences (1453) 1453
adult (1350) 1350
chelating agents (1120) 1120
chelating agents - pharmacology (933) 933
middle aged (917) 917
pharmacology & pharmacy (889) 889
rats (834) 834
mice (826) 826
child (768) 768
iron (767) 767
iron - metabolism (762) 762
adolescent (721) 721
deferoxamine - therapeutic use (714) 714
treatment outcome (706) 706
hematology (696) 696
chelation therapy (672) 672
chelating agents - chemistry (596) 596
abridged index medicus (590) 590
biochemistry & molecular biology (589) 589
toxicology (588) 588
iron overload - drug therapy (585) 585
iron chelating agents - pharmacology (564) 564
pharmacology. drug treatments (549) 549
aged (545) 545
chelation (524) 524
edetic acid - therapeutic use (504) 504
chemistry (455) 455
pyridones - therapeutic use (455) 455
child, preschool (449) 449
time factors (431) 431
oncology (393) 393
health aspects (382) 382
analysis (381) 381
care and treatment (380) 380
iron overload - etiology (378) 378
ferritins - blood (377) 377
physical sciences (377) 377
urology & nephrology (372) 372
chelating agents - administration & dosage (362) 362
iron overload (362) 362
benzoates - therapeutic use (361) 361
neurosciences & neurology (360) 360
triazoles - therapeutic use (359) 359
oxidative stress (350) 350
penicillamine - therapeutic use (341) 341
general & internal medicine (335) 335
lead poisoning - drug therapy (335) 335
transfusion reaction (335) 335
iron chelating agents - administration & dosage (328) 328
deferiprone (327) 327
blood transfusion (323) 323
beta-thalassemia - drug therapy (315) 315
liver - metabolism (313) 313
medicine, general & internal (312) 312
research (311) 311
iron chelating agents - adverse effects (308) 308
neurosciences (304) 304
young adult (304) 304
administration, oral (294) 294
antioxidants (294) 294
thalassemia (294) 294
deferoxamine (289) 289
copper (288) 288
chelating agents - adverse effects (284) 284
dose-response relationship, drug (282) 282
disease models, animal (276) 276
proteins (276) 276
magnetic resonance imaging (270) 270
deferasirox (269) 269
drug therapy, combination (265) 265
metals (263) 263
hepatolenticular degeneration - drug therapy (258) 258
cell line, tumor (253) 253
medicine & public health (253) 253
toxicity (252) 252
chemical and industrial products toxicology. toxic occupational diseases (247) 247
risk factors (245) 245
tissue distribution (242) 242
cancer (237) 237
cell biology (236) 236
copper - metabolism (236) 236
research article (236) 236
metals and various inorganic compounds (235) 235
pediatrics (234) 234
sevelamer (231) 231
succimer - therapeutic use (231) 231
dentistry (229) 229
beta-thalassemia - complications (224) 224
rats, wistar (222) 222
beta-thalassemia - therapy (219) 219
chemistry, medicinal (218) 218
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7331) 7331
French (158) 158
German (110) 110
Russian (103) 103
Japanese (68) 68
Spanish (61) 61
Italian (57) 57
Polish (30) 30
Dutch (27) 27
Chinese (24) 24
Portuguese (24) 24
Czech (12) 12
Romanian (8) 8
Danish (5) 5
Hebrew (5) 5
Hungarian (4) 4
Norwegian (3) 3
Turkish (3) 3
Bulgarian (2) 2
Croatian (2) 2
Lithuanian (2) 2
Slovak (2) 2
Finnish (1) 1
Persian (1) 1
Serbian (1) 1
Slovenian (1) 1
Swedish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


21. Full Text Chelation in metal intoxication—Principles and paradigms
by Aaseth, Jan and Skaug, Marit Aralt and Cao, Yang and Andersen, Ole
Journal of trace elements in medicine and biology, ISSN 0946-672X, 07/2015, Volume 31, pp. 260 - 266
Deferasirox | Deferiprone | DMPS | DMSA | Deferoxamine | Antidotes - pharmacology | Heavy Metal Poisoning | Chelating Agents - administration & dosage | Administration, Oral | Unithiol - therapeutic use | Humans | Deferoxamine - therapeutic use | Poisoning - drug therapy | Penicillamine - therapeutic use | Deferoxamine - adverse effects | Triazoles - pharmacology | Trientine - therapeutic use | Succimer - adverse effects | Succimer - therapeutic use | Benzoates - pharmacology | Pyridones - therapeutic use | Chelating Agents - therapeutic use | Pyridones - adverse effects | Antidotes - therapeutic use | Chelating Agents - adverse effects | Poisoning | Thiols | Analysis | Ethylenediamines | Index Medicus | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
22. Full Text Ceruloplasmin dysfunction and therapeutic potential for Parkinson disease
by Ayton, Scott and Lei, Peng and Duce, James A and Wong, Bruce X. W and Sedjahtera, Amelia and Adlard, Paul A and Bush, Ashley I and Finkelstein, David I
Annals of neurology, ISSN 0364-5134, 04/2013, Volume 73, Issue 4, pp. 554 - 559
Neurosciences | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Ceruloplasmin - deficiency | Iron Chelating Agents - therapeutic use | Parkinson Disease - pathology | Humans | Male | Parkinson Disease - drug therapy | Substantia Nigra - metabolism | Ceruloplasmin - therapeutic use | Case-Control Studies | Mice, Knockout | Animals | Ceruloplasmin - metabolism | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | Female | Aged | Mice | Parkinson Disease - metabolism | Pyridones - therapeutic use | Disease Models, Animal | Dopamine Agents | Parkinson Disease - etiology | Parkinsons disease | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
23. Full Text Deferasirox (ICL670A) effectively inhibits oesophageal cancer growth in vitro and in vivo
by Ford, SJ and Obeidy, P and Lovejoy, DB and Bedford, M and Nichols, L and Chadwick, C and Tucker, O and Lui, GYL and Kalinowski, DS and Jansson, PJ and Iqbal, TH and Alderson, D and Richardson, DR and Tselepis, C
British journal of pharmacology, ISSN 0007-1188, 03/2013, Volume 168, Issue 6, pp. 1316 - 1328
iron chelation | cancer | deferasirox | oesophageal cancer | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Triazoles - administration & dosage | Esophagus - drug effects | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Benzoates - therapeutic use | Esophageal Neoplasms - blood | Humans | Deferoxamine - therapeutic use | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Deferoxamine - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Cisplatin - administration & dosage | Esophageal Neoplasms - pathology | Esophageal Neoplasms - metabolism | Female | Antineoplastic Agents - pharmacology | Iron Chelating Agents - administration & dosage | Iron - blood | Triazoles - therapeutic use | Deferoxamine - pharmacology | Iron Chelating Agents - therapeutic use | Esophagus - metabolism | Cisplatin - pharmacology | Iron - metabolism | Benzoates - administration & dosage | Triazoles - pharmacology | Xenograft Model Antitumor Assays | Esophagus - pathology | Animals | Cisplatin - therapeutic use | Iron Chelating Agents - pharmacology | Tumor Burden - drug effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Mice, Nude | Benzoates - pharmacology | Cell Line, Tumor | Cell Proliferation - drug effects | Mice | Mice, Inbred BALB C | Esophageal Neoplasms - drug therapy | Drug Resistance, Neoplasm - drug effects | Physiological aspects | Anthracyclines | Chemotherapy | Esophageal cancer | Tumors | Cancer | Medical research | Iron | Index Medicus | Research Papers with Commentaries
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
24. Full Text Thiosemicarbazones from the Old to New: Iron Chelators That Are More Than Just Ribonucleotide Reductase Inhibitors
by Yu, Yu and Kalinowski, Danuta S and Kovacevic, Zaklina and Siafakas, Aritee R and Jansson, Patric J and Stefani, Christian and Lovejoy, David B and Sharpe, Philip C and Bernhardt, Paul V and Richardson, Des R
Journal of medicinal chemistry, ISSN 0022-2623, 09/2009, Volume 52, Issue 17, pp. 5271 - 5294
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Chemistry, Medicinal | Science & Technology | Biological and medical sciences | General aspects | Medical sciences | Antineoplastic agents | Pharmacology. Drug treatments | Iron Chelating Agents - therapeutic use | Humans | Iron - chemistry | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - chemistry | Iron - metabolism | Iron Chelating Agents - chemistry | Thiosemicarbazones - chemistry | Animals | Thiosemicarbazones - therapeutic use | Iron Chelating Agents - pharmacology | Ribonucleotide Reductases - antagonists & inhibitors | Antineoplastic Agents - pharmacology | Thiosemicarbazones - pharmacology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
25. Full Text Iron Chelation in the Treatment of Cancer: A New Role for Deferasirox?
by Bedford, Matthew R and Ford, Samuel J and Horniblow, Richard D and Iqbal, Tariq H and Tselepis, Chris
Journal of clinical pharmacology, ISSN 0091-2700, 09/2013, Volume 53, Issue 9, pp. 885 - 891
iron | cancer | deferasirox | tumorigenesis | chelators | Chelators | Deferasirox | Iron | Tumorigenesis | Cancer | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Iron Chelating Agents - therapeutic use | Benzoates - therapeutic use | Humans | Deferoxamine - therapeutic use | Antineoplastic Agents - therapeutic use | Neoplasms - drug therapy | Triazoles - pharmacology | Animals | Iron Chelating Agents - pharmacology | Benzoates - pharmacology | Antineoplastic Agents - pharmacology | Pyridones - therapeutic use | Triazoles - therapeutic use | Antimitotic agents | Dosage and administration | Research | Antineoplastic agents | Clinical medicine | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
26. Full Text Multifunctional gold nanostar-based nanocomposite: Synthesis and application for noninvasive MR-SERS imaging-guided photothermal ablation
by Gao, Yongping and Li, Yongsheng and Chen, Jianzhuang and Zhu, Shaojia and Liu, Xiaohang and Zhou, Liangping and Shi, Ping and Niu, Dechao and Gu, Jinlou and Shi, Jianlin
Biomaterials, ISSN 0142-9612, 2015, Volume 60, pp. 31 - 41
Advanced Basic Science | Dentistry | Photothermal therapy | Gold | Nanocomposite | MRI | SERS | Engineering | Materials Science | Technology | Engineering, Biomedical | Materials Science, Biomaterials | Science & Technology | Gold - chemistry | Nanocomposites - therapeutic use | Nanocomposites - chemistry | Humans | Chelating Agents - chemistry | Magnetic Resonance Imaging - methods | Polyethylene Glycols - chemistry | Spectrum Analysis, Raman - methods | Polyethylene Glycols - therapeutic use | Neoplasms - therapy | Phototherapy - methods | Animals | Heterocyclic Compounds - chemistry | Organosilicon Compounds - chemistry | Organosilicon Compounds - therapeutic use | Cell Line, Tumor | Gold - therapeutic use | Organometallic Compounds - therapeutic use | Nanocomposites - ultrastructure | Organometallic Compounds - chemistry | Mice, Inbred BALB C | Heterocyclic Compounds - therapeutic use | Neoplasms - pathology | Chelating Agents - therapeutic use | Magnetic resonance imaging | Anisotropy | Chelates | Index Medicus | Surgical implants | Biomedical materials | Synthesis | Imaging | Nanostructure | Ablation | Tumors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
27. 3-hydroxypyridinone derivatives as metal-sequestering agents for therapeutic use
by Santos, M Amélia and Chaves, Sílvia
Future medicinal chemistry, ISSN 1756-8919, 03/2015, Volume 7, Issue 3, pp. 383 - 410
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Chemistry, Medicinal | Science & Technology | Iron Chelating Agents - therapeutic use | Animals | Iron Overload - drug therapy | Pyridines - chemistry | Humans | Chelation Therapy | Molecular Structure | Iron Chelating Agents - chemistry | Pyridines - therapeutic use
Journal Article
Details down arrow
28. Full Text Rational Design and Multibiological Profiling of Novel Donepezil–Trolox Hybrids against Alzheimer’s Disease, with Cholinergic, Antioxidant, Neuroprotective, and Cognition Enhancing Properties
by Cai, Pei and Fang, Si-Qiang and Yang, Xue-Lian and Wu, Jia-Jia and Liu, Qiao-Hong and Hong, Hao and Wang, Xiao-Bing and Kong, Ling-Yi
ACS chemical neuroscience, ISSN 1948-7193, 11/2017, Volume 8, Issue 11, pp. 2496 - 2511
acetylcholinesterase inhibitors | antioxidant | Alzheimer's disease | neuroprotection | β-amyloid aggregation | cognitive improvement | Biochemistry & Molecular Biology | Neurosciences | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Neurosciences & Neurology | Chemistry, Medicinal | Science & Technology | Central Nervous System Agents - therapeutic use | Cholinesterase Inhibitors - toxicity | Humans | Amyloid beta-Peptides - drug effects | Male | Structure-Activity Relationship | Indans - therapeutic use | PC12 Cells | Chromans - pharmacology | Piperidines - pharmacology | Drug Design | Copper | Drug Evaluation, Preclinical | Chelating Agents - therapeutic use | Monoamine Oxidase Inhibitors - therapeutic use | Cell Line | Monoamine Oxidase Inhibitors - pharmacology | Piperidines - toxicity | Microglia - drug effects | Oxidants - toxicity | Alzheimer Disease - drug therapy | Rats | Neurotoxins - toxicity | Antioxidants - pharmacology | Chelating Agents - pharmacology | Protein Aggregation, Pathological - drug therapy | Mice, Inbred ICR | Antioxidants - toxicity | Monoamine Oxidase Inhibitors - toxicity | Antioxidants - therapeutic use | Animals | Chelating Agents - toxicity | Cholinesterase Inhibitors - pharmacology | Chromans - therapeutic use | Piperidines - therapeutic use | Central Nervous System Agents - pharmacology | Peptide Fragments - drug effects | Indans - toxicity | Molecular Docking Simulation | Chromans - toxicity | Cholinesterase Inhibitors - therapeutic use | Central Nervous System Agents - toxicity | Blood-Brain Barrier | Indans - pharmacology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights